CANNABIS SATIVA, INC.

FORM 10-Q (Quarterly Report)

Filed 08/19/14 for the Period Ending 06/30/14 Address

Telephone CIK Symbol SIC Code Industry Sector Fiscal Year

1646 W. PIONEER BLVD. SUITE 120 MESQUITE, NV 89027 702-346-3906 0001360442 CBDS 7200 - Services-Personal Services Pharmaceuticals Healthcare 12/31

http://www.edgar-online.com © Copyright 2017, EDGAR Online, Inc. All Rights Reserved. Distribution and use of this document restricted under EDGAR Online, Inc. Terms of Use.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ———————

FORM 10-Q ———————  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2014 or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE  ACT OF 1934 For the transition period from: _____________ to _____________ ——————— Cannabis Sativa, Inc. (Exact name of registrant as specified in its charter) ——————— NEVADA (State or Other Jurisdiction of Incorporation)

000-53571 (Commission File Number)

20-1898270 (I.R.S. Employer Identification No.)

1646 W. Pioneer Blvd., Suite 120, Mesquite, Nevada 89027 (Address of Principal Executive Office) (Zip Code) (702) 346-3906 (Registrant’s telephone number, including area code) (Former name, former address and former fiscal year, if changed since last report) ——————— Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes  No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). 

Yes



No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. Large accelerated filer  Non-accelerated filer 

Accelerated filer  Smaller reporting company 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes



No

The number of shares of the issuer’s Common Stock outstanding as of August 14, 2014 is 15,014,738. INDEX PART I – FINANCIAL INFORMATION Item 1. Financial Statements Condensed Consolidated Balance Sheet – As of June 30, 2014 (Unaudited) and December 31, 2013 Condensed Consolidated Statements of Operations (Unaudited) – For the Three and Six Months Ended June 30, 2014 and from the Date of Inception April 9, 2013 through June 30, 2014 Condensed Consolidated Statements of Cash Flows (Unaudited) – For the Six Months Ended June 30, 2014 and from the Date of Inception April 9, 2013 through June 30, 2014 Notes to Condensed Consolidated Financial Statements Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Item 3.

Quantitative and Qualitative Disclosure About Market Risk

Item 4.

Controls and Procedures

PART II – OTHER INFORMATION Item 1. Legal Proceedings Item 1A.

Risk Factors

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

Item 3.

Defaults Upon Senior Securities

Item 4.

Mine Safety Disclosures

Item 5.

Other Information

Item 6.

Exhibits

SIGNATURES

Index

PART I – FINANCIAL INFORMATION Item 1.

Financial Statements. CANNABIS SATIVA, INC. CONDENSED CONSOLIDATED BALANCE SHEETS ASSETS December 31, 2013

June 30, 2014 (Unaudited) Current Assets Cash and cash equivalents Accounts receivable Inventory Prepaids

$

89,091 $ 1,130 20,063 -

Total Current Assets

110,284

20,616

8,100 13,070,346 3,066,169 140,000 8,938 1,031

2,033 3,782 881

$ 16,404,868 $

27,312

Property and equipment, net Goodwill Intangibles, net Available-for-sale securities Long-term investments Deposits Total Assets

14,863 3,969 1,784

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Current Liabilities Dividends payable Accounts payable and accrued expenses Derivative liability Due to related parties Accrued interest

$

Total Current Liabilities Related party convertible notes payable, net of discount Convertible notes payable, net of discount Due to related parties Total Liabilities Stockholders' Equity (Deficit) Preferred stock, $.001 par value, 5,000,000 shares authorized, none issued or outstanding at June 30, 2014 and December 31, 2013, respectively Common stock, $.001 par value, 45,000,000 shares authorized, 15,014,738 and 7,825,000 issued and outstanding at June 30, 2014 and December 31, 2013, respectively Non-controlling interest Additional paid-in capital Retained deficit

5,245 32,309,105 196,279 4,319

528,237

32,514,948

3,000,000

14,727 2,162 -

3,528,237

32,531,837

-

-

15,015 7,825 894 45,584,310 33,022 (32,723,588) (32,545,372)

Total Stockholders' Equity (Deficit) Total Liabilities and Stockholders' Equity

27,365 15,630 479,575 5,667

12,876,631

(32,504,525)

$ 16,404,868 $

The Accompanying Notes are an Integral Part of these Condensed Consolidated Financial Statements

27,312

Index

CANNABIS SATIVA, INC. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS For the Three and Six Months Ended June 30, 2014 and from the Date of Inception (April 9, 2013) through June 30, 2013 (Unaudited)

For the Three Months Ended June 30, 2014

Revenues

$

For the Six Months Ended June 30, 2014

227 $

1,672 $

-

915

1,631

-

41

-

99,889

165,161

35,322

(100,577)

(165,120)

(35,322)

(3,534)

(13,096)

(104,111)

(178,216)

Cost of goods sold Gross profit

(688)

General and administrative expenses Loss from operations Interest (expense) Income (loss) before income taxes

From the Date of Inception (April 9, 2013) through June 30, 2013

Income taxes

-

-

(35,322) -

Net Income (Loss)

$ (104,111) $ (178,216) $ (35,322)

Net loss per common share Basic and diluted

$

Weighted average common shares; basic and diluted

(0.01) $

11,714,071

The Accompanying Notes are an Integral Part of these Condensed Financial Statements

(0.02) 10,016,293

Index

CANNABIS SATIVA, INC. CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS For the Six Months Ended June 30, 2014 and from the Date of Inception (April 9, 2013) through June 30, 2013 (Unaudited)

For the Six Months Ended June 30, 2014 Cash flows from operating activities: Net loss

For the Period form the Date of Inception (April 9, 2013) thorugh June 30, 2013

$ (178,216) $

(35,322)

1.294 24,188 5,559 (1,130) (5,315) (16,094) 1,784 (150) 10,384 1,348

(1,454) 2,615 -

Net cash used by operating activities

(156,348)

(34,161)

Cash flows from investing activities: Purchase of fixed assets and intangibles Cash acquired in merger

(20,427) 27,707

-

7,280

-

223,296 -

34,602 13

223,296

34,615

Net increase in cash

74,228

454

Cash at beginning of period

14,863

-

Adjustments to reconcile net loss to net cash used by operating activities: Depreciation and amortization Contributed capital Amortization of note discount Loss on derivative liability Changes in assets and liabilities: Accounts receivable Intercompany receivable Inventory Prepaids Deposits Accounts payable and accrued expenses Accrued interest

Net cash provided by investing activities Cash flows from financing activities: Proceeds from related parties Payments to related parties Proceeds from sale of common stock Net cash provided by financing activities

Cash at end of period

$

89,091 $

454

$ 78,112 $ $ 3,198,258 $

-

Supplemental disclosure of cash flow information: Non-cash investing and financing activities: Conversion of debt to equity Acquisition of assets in merger The Accompanying Notes are an Integral Part of these Condensed Financial Statements

Index

CANNABIS SATIVA, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Three and Six Months Ended June 30, 2014 and From the Date of Inception (April 9, 2013) Through June 30, 2013 (Unaudited) 1. Summary of Significant Accounting Policies and Use of Estimates: Presentation of Interim Information: The condensed consolidated financial statements included herein have been prepared by Cannabis Sativa, Inc., formerly named Ultra Sun Corp. (“we”, “us”, “our” or “Company”), without audit, pursuant to the rules and regulations of the United States Securities and Exchange Commission (“SEC”) and should be read in conjunction with the current reports on Form 8-K filed with the SEC July 18, 2013 and July 7, 2014. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, as permitted by the SEC, although we believe the disclosures, which are made, are adequate to make the information presented not misleading. Further, the condensed financial statements reflect, in the opinion of management, all normal recurring adjustments necessary to present fairly our financial position at June 30, 2014, and the results of our operations and cash flows for the periods presented. Interim results are subject to significant seasonal variations and the results of operations for the period ended June 30, 2014 are not necessarily indicative of the results to be expected for the full year. Nature of Corporation: The Company was incorporated under the laws of the State of Nevada on November 5, 2004 under the name Ultra Sun Corp. The Company’s previous operations were in operating a tanning salon business. The Company sold its tanning salon business on September 30, 2013 and plans to conduct all business through its subsidiaries Wild Earth Naturals Inc. (“Wild Earth”) and Kush (“Kush”). On November 13, 2013, the Company filed a Certificate of Amendment to its Articles of Incorporation to change its name to “Cannabis Sativa, Inc.,” effective November 18, 2013. Wild Earth was incorporated under the laws of the State of Nevada on April 9, 2013 for the purpose of operating an herbal products’ business. Kush was incorporated under the laws of the State of Nevada on January 24, 2013 for the purpose of researching, developing and licensing specialized natural cannabis products, including cannabis formulas, edibles, topicals, strains, recipes and delivery systems. On July 12, 2013, the Company, Ultra Merger Corp., a Nevada corporation (“Merger Corp.”) and Wild Earth entered into an Agreement and Plan of Reorganization dated as of July 12, 2013 (the “ Reorganization Agreement”) pursuant to which the Company formed Merger Corp. as a new, wholly-owned subsidiary of the Company, Merger Corp. was merged into Wild Earth with Wild Earth continuing as the surviving corporation, and the Company issued 6,500,000 shares of its restricted common stock to the stockholders of Wild Earth in exchange for all the issued and outstanding shares of Wild Earth capital stock (the “Reorganization”). As a result of the Reorganization, Wild Earth became a wholly owned subsidiary of the Company and the Company had a total of 7,825,000 shares of common stock outstanding of which 6,500,000 or 83.1% were issued to the Wild Earth stockholders. The Reorganization resulted in a change in control of the Company. The transaction has been treated as a recapitalization of the Company and its subsidiaries, with the Company (the legal acquirer of Wild Earth and its subsidiaries) considered the accounting acquiree, and Wild Earth, whose management took control of the Company (the legal acquiree of the Company) considered the accounting acquirer. The Company did not recognize goodwill or any intangible assets in connection with the transaction. All costs related to the transaction are being charged to operations as incurred. The 6,500,000 shares of common stock issued in conjunction with the Reorganization have been presented as outstanding for all periods. The historical consolidated financial statements include the operations of the accounting acquirer for all periods presented.

Index

CANNABIS SATIVA, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Three and Six Months Ended June 30, 2014 and From the Date of Inception (April 9, 2013) Through June 30, 2013 (Unaudited) On June 30, 2014, the Company, CBDS Merger Corp., a Nevada corporation (“Merger Corp.”), and KUSH, a Nevada corporation (“Kush”) entered into an Agreement and Plan of Reorganization dated as of June 30, 2014 (the “ Reorganization Agreement”) pursuant to which the Company formed Merger Corp. as a new, wholly-owned subsidiary of the Registrant, Merger Corp. was merged into Kush with Kush continuing as the surviving corporation, and the Company issued 3,300,667 shares of its restricted common stock to the stockholders of Kush in exchange for all the issued and outstanding shares of Kush capital stock (the “Reorganization”). As a result of the Reorganization, Kush became a wholly owned subsidiary of the Company and the Company had a total of 15,014,738 shares of common stock outstanding, of which 3,300,667 or approximately 22.0% were issued to the Kush stockholders. Use of Estimates: The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Principles of Consolidation The financial statements include the accounts of Cannabis Sativa Inc. and its subsidiaries. Intercompany transactions and balances have been eliminated. Equity investments through which we exercise significant influence over but do not control the investee and are not the primary beneficiary of the investee’s activities are accounted for using the equity method where applicable. Investments through which we are not able to exercise significant influence over the investee and which do not have readily determinable fair values are accounted for under the cost method where applicable. Accounts Receivable We estimate credit loss reserves for accounts receivable on an individual receivable basis. A specific impairment allowance reserve is established based on expected future cash flows and the financial condition of the debtor. We charge off customer balances in part or in full when it is more likely than not that we will not collect that amount of the balance due. We consider any balance unpaid after the contract payment period to be past due. As of June 30, 2014 the Company has not recorded an allowance for doubtful accounts as it fully expects to receive payment. Inventory: The Company calculates inventory using the average cost method to value inventory. Inventory cost includes those costs directly attributable to the product before sale. Fair Value of Financial Instruments: The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts receivable, inventory, accounts payable, accrued liabilities, and notes payable approximate fair value given their short term nature or effective interest rates. Cash and Cash Equivalents: For financial accounting purposes, cash and cash equivalents are considered to be all highly liquid investments purchased with an initial maturity of three (3) months or less.

Index

CANNABIS SATIVA, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Three and Six Months Ended June 30, 2014 and From the Date of Inception (April 9, 2013) Through June 30, 2013 (Unaudited) Intangible Assets: The intangible assets are comprised of patent and trademarks, intellectual property rights, goodwill and the Company’s “CBDS.com” website domain. The intangible assets are being amortized using the straight-line method over its economic life. Earnings per Share: Basic earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the period and contains no dilutive securities. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. As of June 30, 2014, the Company has no outstanding potentially dilutive securities. Revenue Recognition: The Company recognizes revenue from product sales at the time the purchase is made. Income Taxes: The Company estimates the annual tax rate based on projected taxable income for the full year and records a quarterly income tax provision in accordance with the anticipated annual rate. As the year progresses, we refine the estimates of the year’s taxable income as new information becomes available, including year-to-date financial results. This continual estimation process can result in a change to the expected effective tax rate for the year. When this occurs, the Company adjusts the income tax provision during the quarter in which the change in estimate occurs so that the year-to-date provision reflects the expected annual tax rate. Significant judgment may be required in determining the Company’s effective tax rate and in evaluating our tax positions. The effective income tax rate of 0% for the periods ended June 30, 2014 differed from the statutory rate, due primarily to net operating losses incurred by the Company in the respective periods. For the six months ended June 30, 2014 a tax benefit of approximately $60,000 would have been generated. However, all benefits have been fully offset through an allowance account due to the uncertainty of the utilization of the net operating losses. As of June 30, 2014 the Company had net operating losses of approximately $360,000 resulting in a deferred tax asset of approximately $122,000. The Company has established a valuation allowance in the full amount of the deferred tax asset due to the uncertainty of the utilization of operating losses in future periods. Pending Accounting Pronouncements: There have been no recent accounting pronouncements issued which are expected to have a material effect on the Company’s financial statements. 2. Kush Merger On June 30, 2014, the Company, CBDS Merger Corp., a Nevada corporation (“Merger Corp.”), and KUSH, a Nevada corporation (“Kush”) entered into an Agreement and Plan of Reorganization dated as of June 30, 2014 (the “ Reorganization Agreement”) pursuant to which the Company formed Merger Corp. as a new, wholly-owned subsidiary of the Registrant, Merger Corp. was merged into Kush with Kush continuing as the surviving corporation, and the Company issued 3,300,667 shares of its restricted common stock to the stockholders of Kush in exchange for all the issued and outstanding shares of Kush capital stock (the “Reorganization”). As a result of the Reorganization, Kush became a wholly owned subsidiary of the Company and the Company had a total of 15,014,738 shares of common stock outstanding, of which 3,300,667 or approximately 22.0% were issued to the Kush stockholders. The excess of the fair value of stock the stock issued in the transaction over the value of the assets acquired resulted in goodwill of $13,070,346.

Index

CANNABIS SATIVA, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Three and Six Months Ended June 30, 2014 and From the Date of Inception (April 9, 2013) Through June 30, 2013 (Unaudited) Pursuant to the terms of the Reorganization Agreement, at the closing of the Reorganization, the size of the Company’s board of directors was increased from three to five and Steven Kubby and Gary Johnson, directors of Kush, were appointed as directors. In addition, Steven Kubby was appointed as the Chairman of the Board, David Tobias resigned from his positions as President, CEO and Secretary of the Company and Gary Johnson was appointed as the President, CEO and Secretary, to fill the vacancies created by Mr. Tobias’ resignation. Mr. Tobias will continue to serve as a director of the Company and as President and Secretary of Wild Earth Naturals, Inc. The following unaudited proforma condensed combined statement of operations reflects the results of operations of CANNABIS SATIVA (formerly Ultra Sun Corp.) for the six months ended June 30, 2014, the results of operations for WILD EARTH NATURALS for the six months ended June 30, 2014, and the results of operations for KUSH for the six months ended June 30, 2014 as if the Companies had been consolidated effective January 1, 2014 Cannabis Sativa Revenue

$

Wild Earth Naturals

Kush

Proforma

- $

1,672 $

- $

1,672

Cost of revenue

-

1,631

-

1,631

Gross profit

-

41

-

41

General and administrative expense

3,940

161,221

278,374

443,535

Other expense Realized loss on available-for-sale securities Interest expense

6,908

6,188

337,440 -

337,440 13,096

(615,814)

(794,030)

Loss from continued operations Net loss

(10,848) $

(167,368)

(10,848) $ (167,368) $ (615,814) $ (794,030)

The following unaudited proforma condensed combined statement of operations reflects the results of operations of CANNABIS SATIVA (formerly Ultra Sun Corp.) for the six months ended June 30, 2013, the results of operations for WILD EARTH NATURALS for the period from the date of inception (April 9, 2013) through June 30, 2013, and the results of operations for KUSH for the period from the date of inception (January 24, 2013) through June 30, 2013 as if the Companies had been consolidated effective January 1, 2014 . Cannabis Sativa Revenue

$

Wild Earth Naturals

Kush

Proforma

- $

- $

- $

-

Cost of revenue

-

-

-

-

Gross profit

-

-

-

-

35,322

29,852

65,174

(35,322)

(29,852)

(65,174)

General and administrative expense Loss from continued operations

-

Income (loss) from discontinued operations Net loss

(7,764) $

(7,764) $

(35,322) $

(29,852) $

(7,764) (72,938)

Index

CANNABIS SATIVA, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Three and Six Months Ended June 30, 2014 and From the Date of Inception (April 9, 2013) Through June 30, 2013 (Unaudited) 3. Goodwill As of June 30, 2014, the Company recorded $13,070,346 in goodwill as a result of the acquisition of Kush. The balance represents the excess of the fair value of stock issued in the acquisition over the book value of the assets acquired. 4. Intangibles, net As of June 30, 2014 and December 31, 2014, the Company had net intangible assets of $3,066,169 and $3,782, respectively. As of June 30, 2014 and December 31, 2013 intangible assets were comprised of the following:

CBDS.com website (Cannabis Sativa) Patents and Trademarks (Wild Earth) Intellectual Property Rights (Kush) Less: Accumulated Amortization

June 30, December 2014 31, 2013 $ 14,000 4,940 3,790 3,060,000 (12,771) (8) $ 3,066,169 $

3,782

5. Available-for-Sale Securities Our available-for-sale securities are an investment in a marketable trading security. As such it will be adjusted to fair market value at each reporting date. The unrealized price variation will be reflected on our statement of comprehensive income (loss) as well as in our equity section of our balance sheet as an accumulated comprehensive loss. Subsequent to June 30, 2014, the Company has sold all holdings related to the security for proceeds of $147,821. 6. Long Term Investment in KPAL, LLC Kush, a wholly-owned subsidiary of the Company, owns an approximately 90% membership interest in KPAL, LLC, a Texas limited liability company. KPAL, LLC's only assets are the ongoing capitalized costs associated with three patent applications filed with the U.S. Patent and Trademark Office in March and April 2010 with regard to the CTA strain, its use in a lozenge and as a treatment for hypertension. To date, none of the applications has been granted and no patents have issued. Kush is continuing to pursue such applications; however, no assurances can be given that any of the patent applications will result in the issuance of a patent to Kush. All amounts owed at June 30, 2014 to the outside attorney as of that date are being accrued in accounts payable and will be paid by the Company. 7. Convertible Notes Payable – Related Party and Non-Related Party In connection with the Wild Earth Reorganization as noted above, the Company amended and consolidated its outstanding promissory notes having an outstanding balance of principal and accrued interest in the amount of $78,112 as of April 22, 2013. The Company issued new convertible promissory notes to the holders in exchange for their old notes which included the accrued and unpaid interest on the old notes through April 22, 2013 in the principal balance of the new notes. In addition, the notes were amended to extend the maturity date from December 31, 2013 to May 31, 2016, provide that the principal (but not the interest) of the new notes is convertible into shares of the Company’s common stock at the rate 4.25% of the then issued and outstanding shares of the Company’s common stock for each $10,000 in principal converted, provide that the notes may not be prepaid, and make other changes as set forth in the new notes. No payments were made by the Company or the note holders in connection with the amendment and consolidation of the old notes. In connection with the Wild Earth Reorganization, the note holders of the Company sold convertible promissory notes having an aggregate principal balance of $68,112 as of April 22, 2013 to certain stockholders of Wild Earth in private transactions. At April 22, 2013 the principal balance was convertible into 658,533 shares of the Company’s common stock. This conversion feature resulted in a beneficial conversion value of $475,055 and a corresponding note discount in the full value of the principal amounts of the notes. The note discount is being amortized over the remaining life of the notes. Amortization of the note discount for the six months ended June 30, 2014 totaled $5,559 and is included in interest expense for the period presented. During the quarter ended March 31, 2014, the holders of these convertible notes converted the entire outstanding principal balance of $78,112 into 3,889,071 shares of the Company’s common stock. The conversion resulted in the extinguishment of the Company’s $32,309,105 derivative liability outstanding at December 31, 2013 and the remaining unamortized note discount of $55,664. As of June 30, 2014 accrued interest on the convertible notes totaled $5,667 and remains unpaid.

8. Due to Related Parties During the six months ended June 30, 2014 the Company received additional short-term advances from related parties and officers of the Company to cover operating expenses. As of June 30, 2014, net advances to the Company were $419,575. These advances are non-interest bearing in nature. The Company has imputed interest on these sums at the rate of 5% per annum and has recorded interest expense related to these balances in the amount of $6,188. Because the related parties do not expect the imputed interest to be repaid, the interest has been recorded as a contribution of capital at June 30, 2014.

Index

CANNABIS SATIVA, INC. NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Three and Six Months Ended June 30, 2014 and From the Date of Inception (April 9, 2013) Through June 30, 2013 (Unaudited) Kush, a wholly-owned subsidiary of the Company, is a party to three individual license agreements with Steve Kubby. Pursuant to the license agreements Kush owes a total of $3,060,000 in license fees to Mr. Kubby at various dates, all of which has been accrued as of June 30, 2014. The table below represents the future payment schedule due Mr. Kubby related to license agreements: Payment Date: September 30, 2014 July 31, 2015 December 31, 2015 June 30, 2016

Amount Due: $ 60,000 1,000,000 1,000,000 1,000,000

Current Portion Long-Term Portion

$ 3,060,000 60,000 3,000,000

Under the terms of the agreements, in the event any such payment is not made in full when due, and if the stock of Licensee or its parent is publicly traded in the over-the-counter market or on a national exchange, Licensee may pay or the Licensor may elect to be paid the unpaid payment amount in the form of unregistered shares of such publicly traded stock of Licensee or its parent, which shares shall be valued at a 35% discount to the average closing price for such stock in the over-the-counter market or on a national exchange during the 30 trading days preceding the issuance of such shares. 9. Fair Value Measurements We adopted ASC Topic 820 for financial instruments measured at fair value on a recurring basis. ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with accounting principles generally accepted in the United States and expands disclosures about fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • • •

Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

The estimated fair values for financial instruments are determined at discrete points in time based on relevant market information. These estimates involve uncertainties and cannot be determined with precision. The carrying amounts of accounts receivable, inventory, notes payable, accounts payable, accrued liabilities approximate fair value given their short term nature or effective interest rates. We measure certain financial instruments at fair value on a recurring basis. As of June 30, 2014, assets and liabilities measured at fair value on a recurring basis were as follows:

Index

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS For the Three and Six Months Ended June 30, 2014 and From the Date of Inception (April 9, 2013) Through June 30, 2013 (Unaudited) Total

Level 1

Level 2

Level 3

Assets: Available-for-sale securities

$

140,000

$

140,000

$

-

$

-

Total assets measured at fair value

$

140,000

$

140,000

$

-

$

-

Liabilities

$

-

$

-

$

-

$

-

Total liabilities measured at fair value

$

-

$

-

$

-

$

-

10. Going Concern Considerations The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of the Company as a going concern. The Company has incurred net losses since inception. As reported in the financial statements, the Company has an accumulated deficit of $32,723,588. At June 30, 2014, the Company had total current assets of $110,284 and total current liabilities totaling $528,237, and a working capital deficit of $417,953, however, the majority of the assets of the Company are in the form of intangible assets. All of these factors raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on its ability to raise adequate capital to fund operating losses until it is able to engage in profitable business operations. To the extent financing is not available, the Company may not be able to, or may be delayed in, developing its services and meeting its obligations. The Company will continue to evaluate its projected expenditures relative to its available cash and to evaluate additional means of financing in order to satisfy its working capital and other cash requirements. The accompanying financial statements do not reflect any adjustments that might result from the outcome of these uncertainties. 11. Subsequent Events The Company has evaluated subsequent events from the balance sheet date through the date the financial statements were issued, and determined that other than listed below, there are no additional events that require disclosure. Subsequent to June 30, 2014, the Company sold its available-for-sale securities for gross proceeds of $147,821.

Index

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations. General The following is management’s discussion and analysis of certain significant factors affecting the Company’s financial position and operating results during the periods included in the accompanying condensed financial statements. Except for the historical information contained herein, the matters set forth in this discussion are forward-looking statements. Overview We are in the business of developing, manufacturing, and selling plant-derived lotions, creams, and other formulations for human consumption. The Company's market will include direct selling to retailers and consumers, and also to other companies under terms of licensing rights to product formulas. Through the Company’s acquisition of Kush our plan is to engage in developing, producing, marketing and selling end consumer products to the nutriceutical industry containing the hemp plant extract, Cannabidoil (CBD). Results of Operation

Revenue Cost of goods sold Gross profit General and administrative expenses Interest expense Loss from continued operations Net Loss

For the three months ended June 30, 2014 (Unaudited) $ 227 915 (688) 99,889 3,534 (104,111) $ (104,111)

For the period from inception (April 9, 2013) through June 30, 2013 (Unaudited) $ 35,322 (35,322) $ (35,322)

Comparative financial data for the full six months ended June 30, 2013 is not included in this report because the Company was only recently incorporated in April 2013. Revenue – The Company had immaterial revenues related to its ongoing operations for the periods ended June 30, 2014. Cost of Goods Sold – The Company had immaterial cost of goods sold for the periods ended June 30, 2014. General and Administrative Expenses – The Company had general and administrative expenses of $99,889 for the three months ended June 30, 2014 and general and administrative expenses of $35,322 for the period from the date of inception (April 9, 2013) through June 30, 2013 General and administrative expenses consisted primarily of professional fees, consulting expenses, payroll expenses, rent and transfer agent fees.

Index

Interest Expense – The Company had interest expenses of $3,534 for the three months ended June 30, 2014 and $0 for the period from the date of inception (April 9, 2013) through June 30, 2013. Interest expense for the period ended June 30, 2014 was primarily related to the Company’s imputed interest on its advances from related parties. Liquidity and Capital Resources There have been significant changes in our business and financial condition as a result of the Reorganization with Wild Earth Naturals and our acquisition of Kush. We anticipate that we will require significant additional debt or equity capital in order to continue our operations and implement our business plan. We have not entered into any agreement or arrangement for the provision of such financing and no assurances can be given that such financing will be available to us on acceptable terms or at all. We have had to rely on short-term funding from management or shareholders to cover ongoing expenses. There can be no assurance that management and shareholders will continue to loan the Company funds. Forward-Looking Statements We have made forward-looking statements, within the meaning of Section 21E of the Securities and Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, in this quarterly report on Form 10-Q, including the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” that are based on our beliefs and assumptions and on information currently available to us. Forward-looking statements include the information concerning our possible or assumed search for new business opportunities and future costs of operations. Forward-looking statements include all statements that are not historical facts and can be identified by the use of forward-looking terminology such as the words “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. Forward-looking statements involve risks, uncertainties and assumptions. These uncertainties and other factors include, but are not limited to the risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2013 in Part I, Item 1A under the caption “Risk Factors” and in Item 2.01 of our current reports on Form 8-K filed with the Securities and Exchange Commission on July 18, 2013 and July 7, 2014, respectively. Actual results may differ materially from those expressed in the forward-looking statements. You should understand that many important factors could cause our results to differ materially from those expressed in the forward-looking statements. These factors include, without limitation, Kush as a development stage business, the Company’s need for additional capital, our regulatory environment, our limited operating history, our ability to implement our growth strategy, our ability to integrate acquired companies and their assets and personnel into our business, our obligations to pay professional fees, and other economic conditions and increases in corporate maintenance and reporting costs. Unless legally required, we undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Off Balance Sheet Arrangements None Item 3.

Quantitative and Qualitative Disclosures About Market Risk. Not required.

Item 4.

Controls and Procedures. Disclosure Controls and Procedures Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2014, the end of the period covered by this report. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in

Index

the reports it files under the Exchange Act is (i) recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms, and (ii) accumulated and communicated to the company's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding disclosure. Based on this evaluation, management concluded that as of June 30, 2014 our disclosure controls and procedures were not effective due to material weaknesses in our internal control over financial reporting, which is described below. It should be noted that a controls system cannot provide absolute assurance that the objectives of the controls systems are met and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. As disclosed in our annual report on Form 10-K for the fiscal year ended December 31, 2013, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, previously evaluated the effectiveness of the Company’s internal control over financial reporting as of December 31, 2013. In making this evaluation, our management used the COSO framework (1992), an integrated framework for the evaluation of internal controls issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, concluded that as of December 31, 2013, the Company’s internal control over financial reporting was not effective due to a material weakness in our identification and valuation of convertible securities and a lack of segregation of duties. Remedial actions have been and are being implemented to address these controls, including improving processes and communications involving convertible securities, supplementing the technical competence of our accounting staff with contract resources and improving the documentation of the review of the accounting, presentation and disclosure of such securities. As disclosed in the 2013 Form 10-K, we also separated the positions of Chief Executive Officer and Chief Financial Officer, which positions were held by the same person during a portion of 2013. Changes in Internal Control over Financial Reporting Except as described above, there were no changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. PART II – OTHER INFORMATION Item 1.

Legal Proceedings. The Company is not a party to any material pending legal proceedings and, to the best of its knowledge, its properties are not the subject of any such proceedings.

Item 1A.

Risk Factors. See the risk factors discussed in Item 1A. of our Annual Report on Form 10-K for the year ended December 31, 2013, and in Item 2.01 of our current reports on Form 8-K filed with the Securities and Exchange Commission on July 18, 2013 and July 7, 2014.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds. As reported in the current report on Form 8-K filed on July 7, 2014, on June 30, 2014, the Company issued an aggregate of 3,300,667 shares of common stock in relation to the acquisition of Kush. The shares were issued without registration under the Securities Act, in reliance on exemptions from the registration requirements of the Securities Act. The certificates representing the shares were imprinted with customary restricted stock On June 30, 2014, the Company issued an aggregate of 3,300,667 shares of common stock in relation to the acquisition of Kush. The shares were issued without registration under the Securities Act, in reliance on exemptions from the registration requirements of the Securities Act. The certificates representing the shares were imprinted with customary restricted stock legend.

Index

Item 3.

Defaults Upon Senior Securities. None.

Item 4.

Mine Safety Disclosures . None.

Item 5 .

Other Information. None.

Item 6.

Exhibits. The following documents are included as exhibits to this report:

(a) Exhibits Exhibit Number

SEC Reference Number

Title of Document

Location Incorporated by Reference (1) Incorporated by Reference (1) Incorporated by Reference (1) Incorporated by Reference (2) Incorporated by Reference (3) Incorporated by Reference (1) Incorporated by Reference (1) Incorporated by Reference (1) Incorporated by Reference (1) Incorporated by Reference (1) Incorporated by Reference (1) This Filing This Filing This Filing This Filing This Filing This Filing This Filing This Filing This Filing This Filing

2.1

2

2.2

2

2.3

2

3.1

3

Agreement and Plan of Reorganization among the Registrant, CBDS Merger Corp. and Kush dated as of June 30, 2014* Articles of Merger among CBDS Merger Corp. and Kush dated as of June 30, 2014 Plan of Merger among the CBDS Merger Corp. and Kush dated as of June 30, 2014 Articles of Incorporation

3.2

3

Certificate of Amendment to Articles of Incorporation

3.3

3

Bylaws

10.1

10

10.2

10

10.3

10

10.4

10

License Agreement Between Steven Kubby and Kush dated as of June 6, 2014, regarding the NZT Strain License Agreement Between Steven Kubby and Kush dated as of June 6, 2014, regarding MJM License Agreement Between Steven Kubby and Kush dated as of June 6, 2014, regarding the salve/ointment. Employment Agreement with Steven Kubby dated as of June 30, 2014.

10.5

10

Employment Agreement with Gary Johnson dated as of June 30, 2014.

31.1 31.2 32.1 32.2 101.INS (4) 101.SCH (4) 101.CAL (4) 101.DEF (4) 101.LAB (4) 101.PRE (4)

31 31 32 32

Section 302 Certification of Principal Executive Officer Section 302 Certification of Principal Financial Officer Section 1350 Certification of Principal Executive Officer Section 1350 Certification of Principal Financial Officer XBRL Instance Document XBRL Taxonomy Extension Schema XBRL Taxonomy Extension Calculation Linkbase XBRL Taxonomy Extension Definition Linkbase XBRL Taxonomy Extension Label Linkbase XBRL Taxonomy Extension Presentation Linkbase

(1) Incorporated

by reference to the applicable exhibit to the Registrant’s current report on Form 8-K filed on July 7, 2014. by reference to Exhibit 3.01 of the Company’s Registration Statement on Form 10 filed January 28, 2009. (3) Incorporated by reference to Exhibit 3.2 to the Registrant’s quarterly report on Form 10-Q for the fiscal quarter ended March 31, 2014, filed on May 19, 2014. (4) XBRL information is furnished and not filed for purposes of Sections 11 and 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and is not subject to liability under those sections, is not part of any registration statement or prospectus to which it relates and is not incorporated or deemed to be incorporated by reference into any registration statement, prospectus or other documents. (2) Incorporated

Index

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cannabis Sativa, Inc. Date:

August 19, 2014 By: _________________________________ Gary Johnson, President (Principal Executive Officer) By: _________________________________ Catherine Carroll, Chief Financial Officer (Principal Financial and Accounting Officer)

Exhibit 31.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350 (Section 302 of the Sarbanes-Oxley Act of 2002) I, Gary Johnson, certify that: 1. I have reviewed this report on Form 10-Q of Cannabis Sativa, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a15(f) and 15d-15(f)) for the registrant and have; (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Date: August 19, 2014

___________________________________ Gary Johnson President (Principal Executive Officer)

Exhibit 31.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. 1350 (Section 302 of the Sarbanes-Oxley Act of 2002) I, Catherine Carroll, certify that: 1. I have reviewed this report on Form 10-Q of Cannabis Sativa, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a15(f) and 15d-15(f)) for the registrant and have; (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Date: August 19, 2014

__________________________________ Catherine Carroll Chief Financial Officer (Principal Financial Officer)

Exhibit 32.1 Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350 (Section 906 of the Sarbanes-Oxley Act of 2002) I, Gary Johnson, President of Cannabis Sativa, Inc. (the “Registrant”), hereby certify pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that: (1) The Registrant’s accompanying Quarterly Report on Form 10-Q for the quarter ended June 30, 2014 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. Dated: August 19, 2014 By: _____________________________________ Gary Johnson President (Principal Executive Officer) The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of this report.

Exhibit 32.2 Certification of Principal Financial Officer Pursuant to 18 U.S.C. 1350 (Section 906 of the Sarbanes-Oxley Act of 2002) I, Catherine Carroll, Chief Financial Officer of Cannabis Sativa, Inc. (the “Registrant”), hereby certify pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that: (1) The Registrant’s accompanying Quarterly Report of on Form 10-Q for the quarter ended June 30, 2014 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant. Dated: August 19, 2014 By: _____________________________________ Catherine Carroll Chief Financial Officer (Principal Financial Officer) The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being filed as part of this report.